These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 24145052)

  • 1. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.
    Kirbas A; Kirbas S; Cure MC; Tufekci A
    J Clin Neurosci; 2014 Mar; 21(3):451-5. PubMed ID: 24145052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
    Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A
    J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.
    Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A
    Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S; Aslan M; Horoz M; Gur M; Erel O
    Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum paraoxonase, arylesterase activities and oxidative status in patients with insomnia.
    Liang B; Li YH; Kong H
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2517-22. PubMed ID: 24089233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
    Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
    Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of single hemodialysis session on serum paraoxonase-1, arylesterase activity, total oxıdant status and total antioxidant status.
    Yildiz G; Aydin H; Mağden K; Yilmaz A; Hür E; Candan F
    Minerva Med; 2014 Feb; 105(1):79-87. PubMed ID: 24572453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS).
    Baysal E; Taysi S; Aksoy N; Uyar M; Celenk F; Karatas ZA; Tarakcioglu M; Bilinç H; Mumbuç S; Kanlikama M
    Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):770-4. PubMed ID: 22913209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the serum paraoxonase activity and oxidant/antioxidant status in patients with recurrent aphthous stomatitis.
    Bilgili SG; Ozkol H; Takci Z; Ozkol HU; Karadag AS; Aslan M
    Int J Dermatol; 2013 Oct; 52(10):1259-64. PubMed ID: 23834345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of thiols, paraoxonase 1, arylesterase and oxidative balance in colorectal cancer in human.
    Bulbuller N; Eren E; Ellidag HY; Oner OZ; Sezer C; Aydin O; Yılmaz N
    Neoplasma; 2013; 60(4):419-24. PubMed ID: 23581414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Serum Paraoxonase, Arylesterase, Prolidase Activities and Oxidative Stress in Patients with Alopecia Areata.
    Dizen-Namdar N; Emel Kocak F; Kidir M; Sarici G; Tak H; Altuntas I
    Skin Pharmacol Physiol; 2019; 32(2):59-64. PubMed ID: 30544126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major.
    Cakmak A; Soker M; Koc A; Erel O
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):583-7. PubMed ID: 19636263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase and arylesterase activities in fibromyalgia.
    Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S
    Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase and arylesterase activities in coronary artery disease.
    Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
    Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation of the total antioxidant status (TAS), total oxidant status (TOS) and paraoxonase activity (PON1) with smoking.
    Aslan R; Kutlu R; Civi S; Tasyurek E
    Clin Biochem; 2014 Apr; 47(6):393-7. PubMed ID: 24440837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of levothyroxine sodium treatment on oxidative stress in Hashimoto's thyroiditis.
    Ates I; Altay M; Yilmaz FM; Topcuoglu C; Yilmaz N; Berker D; Guler S
    Eur J Endocrinol; 2016 Jun; 174(6):727-34. PubMed ID: 26951600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
    Soyoral YU; Aslan M; Emre H; Begenik H; Erdur FM; Turkel A; Selek S; Erkoc R
    Atherosclerosis; 2011 Sep; 218(1):243-6. PubMed ID: 21723555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urotensin-II level and its association with oxidative stress in early diabetic nephropathy.
    Tabur S; Korkmaz H; Eren MA; Oğuz E; Sabuncu T; Aksoy N
    J Diabetes Complications; 2015; 29(1):115-9. PubMed ID: 25179234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism.
    Cebeci E; Oner FA; Usta M; Yurdakul S; Erguney M
    Acta Biomed; 2011 Dec; 82(3):214-22. PubMed ID: 22783718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
    Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
    Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.